Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
This study evaluates the efficacy and safety of atezolizumab compared with placebo after definitive treatment in patients with squamous cell carcinoma of the head and neck.
This study evaluates the efficacy and safety of atezolizumab compared with placebo after definitive treatment in patients with squamous cell carcinoma of the head and neck.
